首页> 外文期刊>European journal of cardio-thoracic surgery: Official journal of the European Association for Cardio-thoracic Surgery >A combined approach of endobronchial and endoscopic ultrasound-guided needle aspiration in the radiologically normal mediastinum in non-small-cell lung cancer staging--a prospective trial.
【24h】

A combined approach of endobronchial and endoscopic ultrasound-guided needle aspiration in the radiologically normal mediastinum in non-small-cell lung cancer staging--a prospective trial.

机译:非小细胞肺癌分期在放射学正常纵隔内联合支气管内镜和超声引导下穿刺针吸管的方法-前瞻性试验。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: This prospective study aimed to assess the diagnostic yield of the combined approach - endobronchial (EBUS) and endoscopic (EUS) ultrasound-guided needle aspiration (combined ultrasound-needle aspiration (CUS-NA)) in the radiologically normal mediastinum in non-small-cell lung cancer (NSCLC) staging. METHODS: CUS-NA was performed simultaneously under local anaesthesia and sedation in consecutive NSCLC patients with mediastinal nodes that were not enlarged on CT (stage IA-IIB). All patients with negative CUS-NA subsequently underwent the transcervical extended bilateral mediastinal lymphadenectomy (TEMLA) as a confirmatory test. RESULTS: A total of 120 NSCLC patients underwent CUS-NA between 1 January 2008 and 31 December 2008. There were 318 mediastinal nodes biopsied (158 EBUS-NA - stations: 2R - 2, 2L - 1, 4R - 34, 4L - 33 and 7 - 88 and 160 EUS-NA - stations: 4L - 57, 7 - 101 and 9 - 2). CUS-NA revealed metastatic lymph node involvement in 19 of 120 patients (16%) and in 31 of 318 biopsies (10%). The prevalence was 22%. In 99 patients with negative CUS-NA, who underwent subsequent TEMLA, metastatic nodes were diagnosed in nine patients (8%) in 11 stations: 2R - 2, 4R - 4, 4L - 1, 5 - 3 and 7 - 1. In all but one patient there were 'minimal N2' only. Diagnostic sensitivity, specificity, total accuracy, positive predictive value (PPV) and negative predictive value (NPV) of CUS-NA for normal mediastinum was 68% (95% confidence interval (CI): 48-84), 98% (95% CI: 92-100), 91% (95% CI: 86-96), 91% (95% CI: 70-99) and 91% (95% CI: 83-96), respectively. The sensitivity of CUS-NA was significantly higher than with EBUS-NA alone (p=0.04) and higher, close to the level of significance than with EUS-NA alone (p=0.07). The NPV of all techniques was high and that of CUS-NA was significantly higher than EBUS-NA alone and EUS-NA alone (p=0.01, p=0.03). No complications of CUS-NA were observed. CONCLUSIONS: In the radiologically normal mediastinum, CUS-NA is a highly effective and safe technique in NSCLC staging and, if negative, a surgical diagnostic exploration of the mediastinum may be omitted.
机译:目的:这项前瞻性研究旨在评估联合检查在非放射学正常的纵隔放射中的支气管内镜(EBUS)和内镜(EUS)超声引导下穿刺针(超声-针联合穿刺(CUS-NA))的诊断率。小细胞肺癌(NSCLC)分期。方法:在连续麻醉的纵隔淋巴结未行CT放大的IACLC患者(IA-IIB期)中,在局部麻醉和镇静下同时进行CUS-NA。所有CUS-NA阴性的患者随后均行经颈宫颈纵隔双侧纵隔淋巴结清扫术(TEMLA)作为确证性测试。结果:在2008年1月1日至2008年12月31日期间,共有120例非小细胞肺癌患者接受了CUS-NA。活检了318个纵隔淋巴结(158个EBUS-NA-站:2R-2、2L-1、4R-34、4L-33和7-88和160 EUS-NA-电台:4L-57、7-101和9-2)。 CUS-NA显示120例患者中有19例(16%)和318例活检中有31例(10%)转移淋巴结。患病率为22%。在99例CUS-NA阴性的患者中,他们接受了随后的TEMLA治疗,在11个站位中有9名患者(8%)被诊断出转移性淋巴结转移:2R-2,4R-4,4L-1,5-3和7-1。除一名患者外,所有患者均只有“最低氮”。 CUS-NA对正常纵隔的诊断敏感性,特异性,总准确性,阳性预测值(PPV)和阴性预测值(NPV)为68%(95%置信区间(CI):48-84),98%(95%) CI:92-100),91%(95%CI:86-96),91%(95%CI:70-99)和91%(95%CI:83-96)。 CUS-NA的敏感性显着高于单独使用EBUS-NA(p = 0.04),并且比单独使用EUS-NA的敏感性更高(p = 0.07)。所有技术的NPV都很高,而CUS-NA的NPV明显高于单独的EBUS-NA和单独的EUS-NA(p = 0.01,p = 0.03)。没有观察到CUS-NA的并发症。结论:在放射学正常的纵隔中,CUS-NA是非小细胞肺癌分期的一种非常有效和安全的技术,如果阴性,则可以省略对纵隔的外科诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号